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Introduction
============

Breast cancer is the most common cancer among women in the United States and worldwide, excluding non-melanoma skin cancers. As per the National Cancer Institute, estimated new cases of female breast cancer in 2019 were 268, 600 which is 15.2% of all new cancer cases in the United States. The lifetime risk of developing this cancer in a woman is approximately 12.8% at some point during their lifetime, based on the data from 2014-2016 \[[@REF1]\]. However, with recent advancements in screening methods, diagnostic modalities, and treatment options, relative survival has improved from 74.6% in 1975-1979 to 90.6% in 2006 \[[@REF2]\].

Diagnosis and treatment of breast cancer patients are complex with common principles modified by patient\'s unique issues. Breast cancer patients may be broadly divided into three groups: a) those with early-to-advanced-stage disease, i.e., those for whom adjuvant therapies may be offered, b) those with metastatic disease and c) those who are breast cancer survivors (BCS). 

Patient\'s experience of breast cancer, throughout the continuum of their disease, will influence their \"quality of life\" \[[@REF3]\]. This will be strongly influenced by their underlying understanding of their diagnosis, treatment, and prognosis. It is to that end that we devised the questionnaire utilized in this study. We attempted to better elucidate patient\'s knowledge, understanding and insight of their disease, and its treatment, and the impact it has had on their physical and psychological health. Our goal as health care providers (HCP) is to enhance the quality of our patient\'s medical as well as psychological outcomes. To that end, an enhanced understanding of our patients\' underlying insights into their disease will guide us to their improved psychological well-being. At the same time, a well-informed patient would be able in a better way to voice their concern and guide their provider in their care. The first step, therefore, in this process, is to get a \"snapshot\" of the degree of their understanding. 

Materials and methods
=====================

Patients were identified who were enrolled in our breast cancer clinic for treatment or follow-up. A 17-item survey was administered to 110 patients using a convenience sampling method over 12 months. The survey was designed after an extensive literature review with the help of an oncologist and a palliative care specialist and waived by Monmouth Medical Center Institutional Review Board (IRB). The questionnaire was designed to assess the patient\'s knowledge, the impact of diagnosis, and treatment on physical and psychological health, end of life (EoL) care planning (Figures [1](#FIG1){ref-type="fig"}-[3](#FIG3){ref-type="fig"}).
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Most of our patients were insured. The majority of them were English speakers in addition to other languages. Patients were approached by medical residents and research coordinator to fill out the survey. Nurse navigators were present to facilitate the process. Surveys were read out loud for patients with vision problems. Patients were also allowed to take the survey home and bring it back during the next visit.

Results
=======

For a detailed overview of the patient's preference, see Table [1](#TAB1){ref-type="table"}. Of all the included patients, 13.63% were stage 1, 13.63% were stage 2, 12.7% were stage 3, 16.36% were stage 4, 14.5% were BCS. 29.18% of total patients could not specify their disease stage. Patients who were referred for pre-cancerous lesions were excluded.

###### Detailed result of the survey

Please note all responses may not add up to exactly 100% because many patients chose not to answer or chose multiple answers in certain questions.

  ------------ ------------------------------------------------------------------------------------------------------------------------------ -----------
  Serial No.   Items                                                                                                                          Result^1^
  I            Patient Characteristic                                                                                                          
  Ia           Stage 1                                                                                                                        13.63%
  Ib           Stage 2                                                                                                                        13.63%
  Ic           Stage 3                                                                                                                        12.7%
  Id           Stage 4                                                                                                                        16.36%
  Ie           Breast cancer survivor                                                                                                         14.5%
  If           Disease stage unspecified                                                                                                      29.18%
  II           Current understanding of your condition                                                                                         
  1            How do you describe your current knowledge about your condition?                                                                
  1a           Adequate                                                                                                                       90.9%
  1b           Not adequate                                                                                                                   6.4%
  1c           Not sure                                                                                                                       2.7%
  2            Answer question related to your condition.                                                                                      
  2a           Able to record diagnosis                                                                                                       61.8%
  2b           Current treatment                                                                                                              85%
  2c           Stage                                                                                                                          55.45%
  2d           Aware of prognosis                                                                                                              
  2d1.         Good                                                                                                                           30.9%
  2d2.         Bad                                                                                                                            8.19%
  2d3.         Not aware                                                                                                                      59%
  3            Would you like to be more educated?                                                                                             
  3a           Yes                                                                                                                            32.7%
  3b           No                                                                                                                             64.5%
  4            Which of the following components you think need more education about?                                                          
  4a           Risk factors and genetics                                                                                                      11.8%
  4b           Prognosis                                                                                                                      26.3%
  4c           Complication                                                                                                                   24.5%
  4d           Treatment options and side- effects                                                                                            29%
  III          Psychological and social aspects                                                                                                
  5            Do you have any of the following as result of the condition and/ or treatment?                                                  
  5a           Anxiety                                                                                                                        44.5%
  5b           Fear                                                                                                                           27.3%
  5c           Uncertainty                                                                                                                    27.3%
  5d           Sadness                                                                                                                        21.8%
  5e           Effect on personal / family life                                                                                               30.9%
  5f           Effect on work performance                                                                                                     23.6%
  5g           Other issues                                                                                                                   1.8%
  6            Do you want your oncologist to initiate discussions regarding above issues?                                                     
  6a           Yes                                                                                                                            22.73%
  6b           No                                                                                                                             77.27%
  7            What would you want your oncologist to do if you face such issues?                                                              
  7a           Manage them                                                                                                                    57%
  7b           Let your PCP manage                                                                                                            10%
  7c           Referral to psychotherapist                                                                                                    9.01%
  7d           Referral to social worker                                                                                                      11.8%
  7e           Referral to nurse navigator                                                                                                    13.6%
  IV           Physical symptoms related to your condition                                                                                     
  8            Do you currently have following symptoms related to your condition or treatment?                                                
  8a           Pain                                                                                                                           25.45%
  8b           Fatigue                                                                                                                        41.8%
  8c           Nausea                                                                                                                         18.18%
  8d           Vomiting                                                                                                                       4.54%
  8e           Other                                                                                                                          3.63%
  9            Do you think there is a need to pay more attention to these symptoms in subsequent visits?                                      
  9a           Yes                                                                                                                            25.45%
  9b           No                                                                                                                             67.27%
  V            End of life care planning                                                                                                       
  10           Do you think end of life care discussions with your oncologist is an integral component of your overall care?                   
  10a          Response from patients in adjuvant treatment group (early to advanced stage disease)                                            
  10ai         Yes                                                                                                                            34.09%
  10aii        No                                                                                                                             65.91%
  10b          Response from patient with metastatic disease                                                                                   
  10bi         Yes                                                                                                                            44.5%
  10bii        No                                                                                                                             55.5%
  10c          Response from breast cancer survivors                                                                                           
  10ci         Yes                                                                                                                            43.75%
  10cii        No                                                                                                                             56.25%
  11           Have you ever had a discussion about end of life care planning with your oncologist?                                            
  11a          Yes, and within 12 months                                                                                                      4.5%
  11b          Yes, but not within 12 months                                                                                                  10.9%
  11c          Never                                                                                                                          89%
  12           Please select components (multiple) of the end of life care planning you think need to have discussion with your oncologist?    
  12a          Prognosis                                                                                                                      27.27%
  12b          Life expectancy                                                                                                                26.36%
  12c          Effect of treatment on quality of life                                                                                         22.7%
  12d          Your preference on extending survival vs quality of life                                                                       22.7%
  12e          Palliative care                                                                                                                9%
  12f          Hospice                                                                                                                        10.9%
  12g          Advance directive                                                                                                              11.8%
  12h          Involvement of family in decision making                                                                                       13.6%
  13           When would you want to have these discussions?                                                                                  
  13a          Response from patients in adjuvant treatment group (early to advanced stage disease)                                            
  13ai         At diagnosis/ initiation of treatment                                                                                          6.8%
  13aii        When oncologist think it's appropriate                                                                                         72.7%
  13aiii       When you request it                                                                                                            15.9%
  13aiv        When it may affect treatment plan                                                                                              11.3%
  13b          Response from patients with metastatic disease                                                                                  
  13bi         At diagnosis/ initiation of treatment                                                                                          16.6%
  13bii        When oncologist think it's appropriate                                                                                         44.44%
  13biii       When you request it                                                                                                            44.44%
  13biv        When it may affect treatment plan                                                                                              11.11%
  13c          Response from breast cancer survivor                                                                                            
  13ci         At diagnosis/ initiation of treatment                                                                                          12.5%
  13cii        When oncologist think it's appropriate                                                                                         50%
  13ciii       When you request it                                                                                                            12.5%
  13civ        When it may affect treatment plan                                                                                              25%
  14           How frequently?                                                                                                                 
  14a          Once                                                                                                                           40%
  14b          At regular interval mutually decided by patient and oncologist                                                                 32.7%
  14c          Every appointment                                                                                                              5.4%
  ------------ ------------------------------------------------------------------------------------------------------------------------------ -----------

1. Self-reported knowledge by a patient

About 90.9% of our patients mentioned that they have adequate knowledge about their condition, 2.7% reported that they are not sure about their current understanding of the disease while 6.4% felt that their knowledge about their disease is not adequate. In actuality, only 55.45% could identify the stage of their cancer, and out of them, only 16.3% could provide further tumor characteristics. Interestingly, 85% of patients were aware of their treatment plans. 32.7% of our patients desired more education and information about their condition. 11.8% wanted to know more about risk factors, 26.3% about prognosis, 24.5% about complications, and 29% about various available treatment options.

2. Psychological and social aspects

Overall, 44.5% of patients suffered from anxiety, 27.3% were fearful about recurrence, and 27.3% had concerns related to uncertainty about their future; 23.6% of patients mentioned that their work is being affected because of their physical condition; 77.27% of our patients did not want their oncologist to initiate a discussion about these psychosocial issues. However, 57% of them expected their oncologist to manage those symptoms if already diagnosed and 10% of them wanted their primary care physician (PCP) to manage those symptoms.

3. Physical symptoms

Cancer-related fatigue was reported by 41.8% of patients, pain by 25.45%. Other symptoms that were commonly reported were nausea, joint pain, peripheral neuropathy, mouth sores, etc. For our cohort, 67.27% of patients mentioned that they did not feel the necessity for these symptoms to be discussed in subsequent visits, apparently, they were adequately managed.

4. EoL care planning

There were 34.09% of patients in the early stage of cancer, 44.5% in advanced stages of breast cancer, and 43.75% of BCS mentioned that they had EoL discussion with their oncologist. For those who had EoL discussion with their oncologist, they consider prognosis (27.27%), life expectancy (26.36%), the effect of treatment on quality of life, and functional status (22.7%) as the major topics to be focused on.

We noticed a difference between different patient groups regarding their preference for EoL care discussion. Among patient subgroups with early-to-advanced-stage disease on adjuvant treatment, 72.7% wanted this discussion at regular intervals decided by their oncologist, 6.8% wanted it at fixed intervals, 15.9% would prefer discussion when they desired and 11.3% would want it when there is a change in the treatment plan. In the BCS cohort, the majority of them (56%) also wanted to leave this discussion to their oncologist's discretion. 

Patients with metastatic disease (18 patients) in response to EoL care discussion questions responded in the following fashion. 16.66% desire discussion at regular intervals, 44.44% desire discussion at oncologist discretion, 44.44% desire discussion when they want, 11.11% desire discussion at the time of change of therapy. As some patients responded to multiple choices, the percentage did not add up to 100%.

We asked our patients to rate the overall care they are receiving at our clinic on a scale of 1-10, while 1 being the worst and 10 being the best experience. We achieved an aggregate score of 9.22.

To adjudge the appropriateness of our survey, we asked our patients for a response as to whether they felt this survey might help improve their care and communication between their oncologists and them. We received an aggregate rating of 7.93 on the same scale of 1-10.

We also wanted to know if the survey or any of its components caused them any distress. 84.5% of patients were unbothered while 9% of them were distressed because of some survey questions, mostly related to EoL questions. 6.5% of total patients did not respond to this question.

Discussion
==========

In addition to the actual diagnosis of breast cancer, patient\'s knowledge of the specifics of their breast cancer such as stage, prognosis, therapeutic options can be critical to the quality of their journey through their disease. We encountered a disparity between actual knowledge and perceived knowledge in our patients. Patient\'s understanding of their condition modified goals of care and also defined their expectations from their HCP. With a surge in survivorship with the advancement in diagnosis and treatment of cancer, it is imperative that HCP understand the needs and perspectives of their patients of that they solicit the participation of their patients as well. There may be unidentifiable barriers that could limit their ability to relay their concerns. We designed a survey-based study to capture the concerns of these patients, their unmet needs, identify gaps in care, and improve overall patient satisfaction and outcomes. We also tried to analyze the problem from both the patient and physician perspectives.

As our study revealed, patients self-reported knowledge was high at 90.9% but their actual understanding of their disease, staging, and prognosis appeared less and therefore, contradictory. Our findings are consistent with prior studies \[[@REF4]\]. Low educational state, low health literacy, ethnicity, the language barrier could all contribute but is beyond the scope of our research. Improving patient education may lead to better-informed decisions and better adherence to treatment plans. Studies have been previously done to evaluate if increased information access reduced distress in cancer patients \[[@REF5]\]. As per Vogel et al. (2008), patients having breast cancer who were given information had a decreased level of anxiety and feeling of insecurity \[[@REF6]\]. 80% of our cohort requested more information with the majority of them having concerns related to prognosis, future complications, and treatment options. Exploring further patient\'s concerns and providing supportive care could be attempted through various methods including internet-based education, telephone counseling, involving breast health specialists, and navigator in care \[[@REF7],[@REF8]\].

We reached an intriguing conclusion about the role of oncologists in the psychosocial well-being of breast cancer patients. 77.27% of all our patients preferred their oncologist not to initiate discussion on psychosocial issues, however, 55.27% of the 77.27% would want their oncologists to address those issues if they already have been diagnosed with any psychosocial issues. What does that mean? Cancer patients may have multiple psychological issues that can go undetected or be attributed to adjustment, grief, or stress. Some patients who have lower cancer-related health education also tend to minimize their symptoms which can have quite a serious impact including depression, suicidal tendencies, refusal of treatment in advanced cases, etc. \[[@REF8],[@REF9]\]. Patients might not request the additional provision of information when they have knowledge gaps. During the clinical encounter, clinical practitioners should assess the individual educational needs and tailor the education accordingly. Health care providers should continue assessing the informational needs of a patient during different stages of the treatment, realizing at the beginning patients' and families can be overwhelmed by the information provided. This can lead to misunderstanding the information and new questions may emerge along the treatment process.

As there is generally a strong relationship between oncologists and patients, patients often presume their oncologist would address any symptoms related to the cancer diagnosis. Oncologists, on the other hand, may feel poorly equipped to handle general health issues or not related to cancer and may expect the participation of the PCP for those issues. It\'s quite possible that patients may confuse the role of their physicians. Our study emphasizes a need for better coordination of care among physicians. Lack of clear guidelines to the patient of which physician is responsible for which symptoms may compromise comprehensive care \[[@REF10]\]. Practical tools such as the Hospital and Anxiety Depression Scale (HADS) and the Brief Symptom Inventory (BSI) have also been shown to be helpful to monitor psychological states across the disease trajectory \[[@REF11]\]. However, this needs better coordination of care between HCPs. Some studies have shown that there is a disconnect between patient and physician, among physicians (PCP, oncologist, other subspecialties) as well which may lead to gaps in care \[[@REF11]-[@REF14]\].

Another spectrum of patient education is the EoL care discussion. Patients who are not well aware of their tumor staging and prognosis may fail to understand the importance of EoL care discussion and palliative care which may complicate care moving forward. As per one study, physicians tend to withhold information if a patient has a poor prognosis concerned that their patient may lose hope in treatment \[[@REF15],[@REF16]\]. Patients who have a relatively lower level of understanding of their disease process may think in a similar fashion. Oncologists play a critical role in caring for a patient with cancer through treatment and in some cases to the EoL \[[@REF16],[@REF17]\]. In our study, we found that only 44.5% of our patients with advanced disease wanted to have EoL discussion while 55.5% deferred it. Lack of proper cancer knowledge may lead to a lower desire for disease information due to a higher preference for a passive decision-making approach, being less autonomous in regards to decisions of medical care. EoL care discussion may provide a more realistic insight into their condition, especially in advanced cancer patients. It should include discussion of comprehension of prognosis, life expectancy, treatment options, side effects of treatment, quality of life. As per Saraiya et al. (2008), improvements in patient decision making and clinical practice can reduce the burden of symptoms for patients if clinicians gain a better understanding of patient\'s expectations respecting the longer-term consequences of diagnosis and treatment \[[@REF18]\]. Early integration of palliative care in cancer improves symptom control, end-of-life care, health-related communication, and continuity of care \[[@REF19]\].

Breast cancer patients often experience complications related to the disease itself, chemotherapy, and surgery. Cancer-related fatigue is very common and affects work and daily performance \[[@REF20],[@REF21]\]. Patients on aromatase inhibitor frequently experience pain, musculoskeletal symptoms among other side effects \[[@REF22]\]. Chronic arm lymphedema after breast surgery impairs physical performance and studies have shown that early mobilization and rehabilitation have improved outcomes \[[@REF23]\]. It is imperative that the patient\'s physical symptoms be addressed early and adequately as physical disability often leads to depression \[[@REF24]\].

Our study has certain limitations and strengths. It's a single-center study with a relatively small study population. Our patients come from various ethnicities and backgrounds. However, we did not analyze our data in a way to accommodate cultural and ethnic variation in regards to their perspective towards disease and treatment. We propose a future multicenter study with a larger patient population with higher variation to validate our study. There can be a difference in patient perspective based on cancer type and prognosis which needs to be studied further. The final aim is to create a better method for the care of cancer patients tailored to their individual needs and eliminating gaps in care.

Conclusions
===========

Our study attempts to measure the level of awareness related to breast cancer diagnosis and its complications among our patients and highlights its impact on their overall care. Management of breast cancer is not limited to therapeutic measures only but also includes psycho-social wellness and EoL care discussion, particularly for patients with metastatic disease. The psychosocial aspect of management remains poorly understood in clinical practice and relatively neglected and that the cause of this is multifactorial. Lack of clear guidelines and disconnect between patients and physician and among physicians themselves contribute to the gap in care. Patient education will lead to an improvement in communication between patient and physician and eventually improve outcomes. Through our research, we also tried to understand patient perspective in their care. The bigger question that remains unanswered is how to increase patient's involvement in their care at every step. We need better ways to improve the education, communication, and decision-making capacity of our patients. With the improvement in breast cancer survivorship, medical care of such patients is an emerging area for quality improvement.
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